Roche Obesity-pill Trial Results Weigh on Shares of Eli Lilly, Novo Nordisk

Shares of weight-loss drugmakers including Eli Lilly & Co., Novo Nordisk A/S and Structure Therapeutics Inc. fell on Wednesday after Roche Holding AG announced positive early-stage trial data for its experimental obesity pill.

MarketWatchJul 17 12:54 ET

Altimmune (NASDAQ:ALT) Is In A Good Position To Deliver On Growth Plans

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, Altimmune (NASDAQ:ALT) shareholders have done very

Simply Wall StJul 15 09:39 ET

B.Riley Financial Maintains Altimmune(ALT.US) With Buy Rating

B.Riley Financial analyst Mayank Mamtani maintains $Altimmune(ALT.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 27.8% and a total average return of -16.5% over

Moomoo NewsJul 12 11:31 ET · Ratings

These Are the Weight Loss Drug Stocks With the Most Upside - SA Sentiment Survey

Seeking AlphaJul 12 10:50 ET

This Weight Loss Stock Is the Best Alternative to Eli Lilly, Novo - SA Sentiment

Seeking AlphaJul 12 04:12 ET

Better GLP-1 Biotech Stock: Altimmune Vs. Viking Therapeutics

Yahoo FinanceJul 10 06:41 ET